Q&A with QIAGEN about Ipsogen buy
Q&A with QIAGEN about Ipsogen buy FierceMedicalDevice
View ArticleQIAGEN Reaches Agreement To Buy 61% Stake In Ipsogen, Plans To Fully Acquire...
QIAGEN Reaches Agreement To Buy 61% Stake In Ipsogen, Plans To Fully Acquire Leader In Oncology Molecular Diagnostics Yahoo/PR NewsWire
View ArticleQiagen Hikes Cellestis' Offer Price
Qiagen Hikes Cellestis' Offer Price Yahoo/Zacks.com
View ArticleQIAGEN amends offer for Cellestis, provides update on Ipsogen
QIAGEN amends offer for Cellestis, provides update on Ipsogen FierceMedicalDevice
View ArticleQiagen's CEO Discusses Q2 2011 Results - Earnings Call Transcript
Qiagen's CEO Discusses Q2 2011 Results - Earnings Call Transcript Seeking Alpha
View ArticleQiagen Completes Second U.S. Submission For Companion Diagnostic To Guide...
Qiagen Completes Second U.S. Submission For Companion Diagnostic To Guide Treatment Decisions In Colorectal Cancer Biomed Reports
View ArticleQiagen: FDA Submissions May Make This Bottom Bouncer More Appealing
Qiagen: FDA Submissions May Make This Bottom Bouncer More Appealing Seeking Alpha
View ArticleQiagen Closes Cellestis Acquisition
Qiagen Closes Cellestis Acquisition Yahoo/Zacks.com
View ArticleAre You Watching This Trend at Illumina?
Are You Watching This Trend at Illumina? Motley Fool
View ArticleQIAGEN to cut up to 10% of workforce
QIAGEN to cut up to 10% of workforce FierceMedicalDevice
View ArticleFDA OKs screening test for colon cancer drug
FDA OKs screening test for colon cancer drug Yahoo/AP
View ArticlePersonalized Medicine Plus Diagnostics Equals Profits for Investors
Personalized Medicine Plus Diagnostics Equals Profits for Investors Motley Fool
View ArticleIllumina countersues Intelligent Bio-Systems and Qiagen
Illumina countersues Intelligent Bio-Systems and Qiagen Reuters
View ArticleChina Biotech In Review: WuXi AppTec And MedImmune Start Joint Venture
China Biotech In Review: WuXi AppTec And MedImmune Start Joint Venture Seeking Alpha
View Article4 Stories to Watch This Week in the Health-Care Sector
4 Stories to Watch This Week in the Health-Care Sector Motley Fool
View ArticleQiagen seeks FDA sign-off for lung cancer companion Dx
Qiagen seeks FDA sign-off for lung cancer companion Dx FierceMedicalDevice
View ArticleQiagen and Lilly expand diagnostic partnership
Qiagen and Lilly expand diagnostic partnership Yahoo/AP
View ArticleChina Biotech In Review: Valeant Pharma Gains Sales Foothold In China With...
China Biotech In Review: Valeant Pharma Gains Sales Foothold In China With Bausch & Lomb Buy Seeking Alpha
View Article